Inventor
WEIFANG SHAN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides13%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
12,145,927Inhibitors of indoleamine 2,3-dioxygenase and methods of their use202412,059,420Inhibitors of indoleamine 2,3-dioxygenase and methods of their use202411,649,212Inhibitors of indoleamine 2,3-dioxygenase and methods of their use202311,548,870Compounds useful as inhibitors of helios protein202311,337,970Inhibitors of indoleamine 2,3-dioxygenase and methods of their use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to BRISTOL MYERS SQUIBB CO (5)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 5 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2024 |